Previous 10 | Next 10 |
home / stock / ektaf / ektaf news
Year-end report, May-April 2020/21 Accelerated order growth PR Newswire STOCKHOLM , May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we...
Accuray has a portfolio of radiotherapy products that are generating revenues of ~$380m per annum. The company is one of only a few competitors in an exciting growth space and area of unmet need, although its competitors are far bigger and better resourced. Its sales have been fla...
The following slide deck was published by Elekta AB (publ) in conjunction with their 2021 Q3 earnings call. For further details see: Elekta AB (publ) 2021 Q3 - Results - Earnings Call Presentation
Elekta AB (publ) (EKTAF): FQ3 GAAP EPS of SEK0.84.Revenue of SEK3.58B (-2.2% Y/Y).Press Release For further details see: Elekta AB (publ) reports FQ3 results
Elekta (EKTAF) appoints acting CFO Johan Adebäck as permanent CFO with immediate effect. Prior to the Acting CFO position, Johan Adebäck had been Group Treasurer at Elekta since 2004, responsible for Treasury, Taxes, Customer Financing, Operational accounting and Customer Credi...
Elekta appoints Johan Adebäck as Chief Financial Officer PR Newswire STOCKHOLM , Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He h...
Elekta establishes office in Egypt to meet growing need for precision radiation medicine Demand for healthcare services and technology presents strong growth potential PR Newswire STOCKHOLM , Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced tod...
Elekta's ProKnow to help standardize radiotherapy for veterans Cloud-based ProKnow will enable peer review across Veterans Affairs network PR Newswire ATLANTA , Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Vet...
Elekta AB (EKTAF) has sold its 7.3% of the outstanding common stock (11,501,597 shares) in ViewRay (VRAY) for ~$53M The shares in ViewRay were purchased in a public offering in December 2019 at $3.13/share and sold at $4.65/share.The sale resulted in a gain of ~17.5M, which will be booked in ...
Elekta divests its stake in ViewRay PR Newswire STOCKHOLM , Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no rema...
News, Short Squeeze, Breakout and More Instantly...
Elekta B Shs Company Name:
EKTAF Stock Symbol:
OTCMKTS Market:
Invitation to the presentation of Elekta's second quarter 2021/22 PR Newswire STOCKHOLM , Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25 . The ...
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration PR Newswire ATLANTA , June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced t...
Year-end report, May-April 2020/21 Accelerated order growth PR Newswire STOCKHOLM , May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we...